Renaissance Technologies’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.3M | Sell |
3,146,053
-402,935
| -11% | -$7.34M | 0.08% | 292 |
|
|
2025
Q1 | $70.4M | Sell |
3,548,988
-220,900
| -6% | -$4.38M | 0.11% | 231 |
|
|
2024
Q4 | $64.7M | Buy |
3,769,888
+102,692
| +3% | +$1.76M | 0.1% | 244 |
|
|
2024
Q3 | $73.3M | Buy |
3,667,196
+1,085,061
| +42% | +$21.7M | 0.11% | 217 |
|
|
2024
Q2 | $28.9M | Buy |
2,582,135
+575,100
| +29% | +$6.43M | 0.05% | 453 |
|
|
2024
Q1 | $13.2M | Buy |
2,007,035
+949,100
| +90% | +$6.26M | 0.02% | 846 |
|
|
2023
Q4 | $4.78M | Sell |
1,057,935
-338,620
| -24% | -$1.53M | 0.01% | 1380 |
|
|
2023
Q3 | $5M | Buy |
1,396,555
+182,820
| +15% | +$655K | 0.01% | 1315 |
|
|
2023
Q2 | $4.48M | Buy |
1,213,735
+240,500
| +25% | +$888K | 0.01% | 1484 |
|
|
2023
Q1 | $3.22M | Buy |
973,235
+277,300
| +40% | +$918K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $2.7M | Buy |
695,935
+57,535
| +9% | +$223K | ﹤0.01% | 1894 |
|
|
2022
Q3 | $1.55M | Sell |
638,400
-87,100
| -12% | -$212K | ﹤0.01% | 2202 |
|
|
2022
Q2 | $1.44M | Buy |
725,500
+198,800
| +38% | +$393K | ﹤0.01% | 2446 |
|
|
2022
Q1 | $964K | Buy |
526,700
+177,800
| +51% | +$325K | ﹤0.01% | 2748 |
|
|
2021
Q4 | $492K | Buy |
348,900
+113,900
| +48% | +$161K | ﹤0.01% | 3082 |
|
|
2021
Q3 | $266K | Buy |
235,000
+59,374
| +34% | +$67.2K | ﹤0.01% | 3117 |
|
|
2021
Q2 | $281K | Buy |
+175,626
| New | +$281K | ﹤0.01% | 3166 |
|
|
2018
Q4 | – | Sell |
-188,300
| Closed | -$1.17M | – | 3349 |
|
|
2018
Q3 | $1.17M | Buy |
188,300
+159,100
| +545% | +$988K | ﹤0.01% | 2538 |
|
|
2018
Q2 | $132K | Buy |
+29,200
| New | +$132K | ﹤0.01% | 3121 |
|
|
2017
Q4 | – | Sell |
-20,300
| Closed | -$63K | – | 3307 |
|
|
2017
Q3 | $63K | Buy |
20,300
+9,000
| +80% | +$27.9K | ﹤0.01% | 3117 |
|
|
2017
Q2 | $42K | Buy |
+11,300
| New | +$42K | ﹤0.01% | 3131 |
|